Abstract
The majority of pediatric renal tumors are Wilms’ tumors. Of particular concern are those renal neoplasms carrying malignant potential. These entities are given particular attention in this chapter. Universally, partial and radical nephrectomies are used to treat both benign and malignant neoplasms. Chemotherapies have improved the prognosis of many malignant renal tumors, such as Wilms, but others, especially those carrying INI-1 mutations, remain difficult to treat and have high mortality rates. More molecular and genetic research is needed to fully understand and successfully treat this subset of childhood tumor.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ko EY, Ritchey ML. Current management of Wilms’ tumor in children. J Pediatr Urol. 2009;5(1):56–65.
Murphy WM, Grignon DJ, Perlman EJ. Kidney tumors in children. In: Silverberg SG, Sobin LH, editors. Tumors of the kidney, bladder, and related urinary structures. Washington, DC: American Registry of Pathology; 2004. p. 1–99.
Shen SS, et al. Recently described and emphasized entities of renal neoplasms. Arch Pathol Lab Med. 2007;131(8):1234–43.
Lall A, et al. Wilms’ tumor with intracaval thrombus in the UK Children’s Cancer Study Group UKW3 trial. J Pediatr Surg. 2006;41(2):382–7.
Servaes S, et al. Comparison of diagnostic performance of CT and MRI for abdominal staging of pediatric renal tumors: a report from the Children’s Oncology Group. Pediatr Radiol. 2014 Aug 19. [Epub ahead of print].
Brisse HJ, et al. Imaging in unilateral Wilms tumour. Pediatr Radiol. 2008;38(1):18–29.
Charles AK, Vujanić GM, Berry PJ. Renal tumours of childhood. Histopathology. 1998;32(4):293–309.
Sebire NJ, Vujanic GM. Paediatric renal tumours: recent developments, new entities and pathological features. Histopathology. 2009;54(5):516–28.
Chu A, et al. Wilms’ tumour: a systematic review of risk factors and meta-analysis. Paediatr Perinat Epidemiol. 2010;24(5):449–69.
Nakamura L, Ritchey M. Current management of wilms’ tumor. Curr Urol Rep. 2010;11(1):58–65.
Davidoff AM. Wilms’ tumor. Curr Opin Pediatr. 2009;21(3):357–64.
Keaney CM, Springate JE. Cancer and the kidney. Adolesc Med Clin. 2005;16(1):121–48.
Lowe LH, et al. Pediatric renal masses: Wilms tumor and beyond. Radiographics. 2000;20(6):1585–603.
Ritchey ML, et al. Renal vein involvement with nephroblastoma: a report of the National Wilms’ Tumor Study-3. Eur Urol. 1990;17(2):139–44.
Khanna G, et al. Evaluation of diagnostic performance of CT for detection of tumor thrombus in children with Wilms tumor: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2012;58(4):551–5.
Khanna G, et al. Detection of preoperative Wilms tumor rupture with CT: a report from the Children’s Oncology Group. Radiology. 2013;266(2):610–7.
Ehrlich PF. Bilateral Wilms’ tumor: the need to improve outcomes. Expert Rev Anticancer Ther. 2009;9(7):963–73.
Rohrschneider WK, et al. US, CT and MR imaging characteristics of nephroblastomatosis. Pediatr Radiol. 1998;28(6):435–43.
Choueiri TK, et al. BRAF mutations in metanephric adenoma of the kidney. Eur Urol. 2012;62(5):917–22.
Schmelz HU, et al. Metanephric adenoma of the kidney: case report and review of the literature. Int Urol Nephrol. 2005;37(2):213–7.
Davis Jr CJ, et al. Metanephric adenoma. Clinicopathological study of fifty patients. Am J Surg Pathol. 1995;19(10):1101–14.
Arroyo MR, et al. The spectrum of metanephric adenofibroma and related lesions: clinicopathologic study of 25 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25(4):433–44.
Hennigar RA, Beckwith JB. Nephrogenic adenofibroma. A novel kidney tumor of young people. Am J Surg Pathol. 1992;16(4):325–34.
Hoglund HH, et al. Ossifying renal tumor of infancy (ORTI)—a rare diagnosis. Klin Padiatr. 2011;223(3):178–9.
Argani P, Beckwith JB. Metanephric stromal tumor: report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol. 2000;24(7):917–26.
Kacar A, et al. Metanephric stromal tumor: a challenging diagnostic entity in children. J Pediatr Surg. 2011;46(12):e7–10.
Grundy P, et al. Clinicopathologic correlates of loss of heterozygosity in Wilm’s tumor: a preliminary analysis. Med Pediatr Oncol. 1996;27(5):429–33.
Argani P, Collins MH. Anaplastic nephrogenic rest. Am J Surg Pathol. 2006;30(10):1339–41.
Beckwith JB. Nephrogenic rests and the pathogenesis of Wilms tumor: developmental and clinical considerations. Am J Med Genet. 1998;79(4):268–73.
Lonergan GJ, et al. Nephrogenic rests, nephroblastomatosis, and associated lesions of the kidney. Radiographics. 1998;18(4):947–68.
Beckwith JB. Precursor lesions of Wilms tumor: clinical and biological implications. Med Pediatr Oncol. 1993;21(3):158–68.
Beckwith JB, Kiviat NB, Bonadio JF. Nephrogenic rests, nephroblastomatosis, and the pathogenesis of Wilms’ tumor. Pediatr Pathol. 1990;10(1–2):1–36.
Fukuzawa R, Reeve AE. Molecular pathology and epidemiology of nephrogenic rests and Wilms tumors. J Pediatr Hematol Oncol. 2007;29(9):589–94.
Charles AK, Brown KW, Berry PJ. Microdissecting the genetic events in nephrogenic rests and Wilms’ tumor development. Am J Pathol. 1998;153(3):991–1000.
Hennigar RA, O’Shea PA, Grattan-Smith JD. Clinicopathologic features of nephrogenic rests and nephroblastomatosis. Adv Anat Pathol. 2001;8(5):276–89.
Park S, et al. Inactivation of WT1 in nephrogenic rests, genetic precursors to Wilms’ tumour. Nat Genet. 1993;5(4):363–7.
Steenman M, et al. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet. 1997;77(3–4):296–303.
Ritchey ML, et al. Fate of bilateral renal lesions missed on preoperative imaging: a report from the National Wilms Tumor Study Group. J Urol. 2005;174(4 Pt 2):1519–21. discussion 1521.
Gylys-Morin V, et al. Wilms tumor and nephroblastomatosis: imaging characteristics at gadolinium-enhanced MR imaging. Radiology. 1993;188(2):517–21.
Hausegger KA, et al. Can MR contribute to the diagnosis of nephroblastomatosis? A report of one case. Pediatr Radiol. 1991;21(7):533–5.
Perlman EJ, et al. Hyperplastic perilobar nephroblastomatosis: long-term survival of 52 patients. Pediatr Blood Cancer. 2006;46(2):203–21.
Joshi VV, Beckwith JB. Multilocular cyst of the kidney (cystic nephroma) and cystic, partially differentiated nephroblastoma. Terminology and criteria for diagnosis. Cancer. 1989;64(2):466–79.
Joshi VV, et al. Cystic partially differentiated nephroblastoma: a clinicopathologic entity in the spectrum of infantile renal neoplasia. Cancer. 1977;40(2):789–95.
Truong LD, et al. Renal cystic neoplasms and renal neoplasms associated with cystic renal diseases: pathogenetic and molecular links. Adv Anat Pathol. 2003;10(3):135–59.
Blakely ML, et al. Outcome of children with cystic partially differentiated nephroblastoma treated with or without chemotherapy. J Pediatr Surg. 2003;38(6):897–900.
Agrons GA, et al. Multilocular cystic renal tumor in children: radiologic-pathologic correlation. Radiographics. 1995;15(3):653–69.
Bahubeshi A, et al. Germline DICER1 mutations and familial cystic nephroma. J Med Genet. 2010;47(12):863–6.
Bayindir P, et al. Cellular mesoblastic nephroma (infantile renal fibrosarcoma): institutional review of the clinical, diagnostic imaging, and pathologic features of a distinctive neoplasm of infancy. Pediatr Radiol. 2009;39(10):1066–74.
England RJ, et al. Mesoblastic nephroma: a report of the United Kingdom children’s cancer and leukaemia group (CCLG). Pediatr Blood Cancer. 2011;56(5):744–8.
Furtwaengler R, et al. Mesoblastic nephroma—a report from the Gesellschaft fur Padiatrische Onkologie und Hamatologie (GPOH). Cancer. 2006;106(10):2275–83.
Gupta R, et al. Cellular mesoblastic nephroma in an infant: report of the cytologic diagnosis of a rare paediatric renal tumor. Diagn Cytopathol. 2009;37(5):377–80.
Chaudry G, et al. Imaging of congenital mesoblastic nephroma with pathological correlation. Pediatr Radiol. 2009;39(10):1080–6.
Irsutti M, et al. Mesoblastic nephroma: prenatal ultrasonographic and MRI features. Pediatr Radiol. 2000;30(3):147–50.
Portugal R, Barroca H. Clear cell sarcoma, cellular mesoblastic nephroma and metanephric adenoma: cytological features and differential diagnosis with Wilms tumour. Cytopathology. 2008;19(2):80–5.
Rubin BP, et al. Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma. Am J Pathol. 1998;153(5):1451–8.
Henno S, et al. Cellular mesoblastic nephroma: morphologic, cytogenetic and molecular links with congenital fibrosarcoma. Pathol Res Pract. 2003;199(1):35–40.
Steelman C, et al. Unusual presentation of congenital infantile fibrosarcoma in seven infants with molecular-genetic analysis. Fetal Pediatr Pathol. 2011;30(5):329–37.
Brownlee NA, et al. Recurring translocation (10;17) and deletion (14q) in clear cell sarcoma of the kidney. Arch Pathol Lab Med. 2007;131(3):446–51.
Gooskens SL, et al. Clear cell sarcoma of the kidney: a review. Eur J Cancer. 2012;48(14):2219–26.
Argani P, et al. Clear cell sarcoma of the kidney: a review of 351 cases from the National Wilms Tumor Study Group Pathology Center. Am J Surg Pathol. 2000;24(1):4–18.
Cutcliffe C, et al. Clear cell sarcoma of the kidney: up-regulation of neural markers with activation of the sonic hedgehog and Akt pathways. Clin Cancer Res. 2005;11(22):7986–94.
Amin MB, et al. Clear cell sarcoma of kidney in an adolescent and in young adults: a report of four cases with ultrastructural, immunohistochemical, and DNA flow cytometric analysis. Am J Surg Pathol. 1999;23(12):1455–63.
Watts KE, Hansel DE, MacLennan GT. Clear cell sarcoma of the kidney. J Urol. 2011;185(1):279–80.
Glass RB, Davidson AJ, Fernbach SK. Clear cell sarcoma of the kidney: CT, sonographic, and pathologic correlation. Radiology. 1991;180(3):715–7.
O’Meara E, et al. Characterization of the chromosomal translocation t(10;17)(q22;p13) in clear cell sarcoma of kidney. J Pathol. 2012;227(1):72–80.
Schuster AE, et al. Genetic and genetic expression analyses of clear cell sarcoma of the kidney. Lab Invest. 2003;83(9):1293–9.
Desai SR, Upadhyay V. Rhabdoid tumour of the kidney: a diagnostic challenge and a fatal outcome. Pediatr Surg Int. 2000;16(5–6):449–50.
Weeks DA, et al. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms’ Tumor Study Pathology Center. Am J Surg Pathol. 1989;13(6):439–58.
Winger DI, et al. Radiology-Pathology Conference: rhabdoid tumor of the kidney. Clin Imaging. 2006;30(2):132–6.
Yamamoto M, et al. Treatment of stage IV malignant rhabdoid tumor of the kidney (MRTK) with ICE and VDCy: a case report. J Pediatr Hematol Oncol. 2006;28(5):286–9.
Han TI, et al. Rhabdoid tumour of the kidney: imaging findings. Pediatr Radiol. 2001;31(4):233–7.
Sisler CL, Siegel MJ. Malignant rhabdoid tumor of the kidney: radiologic features. Radiology. 1989;172(1):211–2.
Palmer NF, Sutow W. Clinical aspects of the rhabdoid tumor of the kidney: a report of the National Wilms’ Tumor Study Group. Med Pediatr Oncol. 1983;11(4):242–5.
Nagata T, et al. Molecular genetic alterations and gene expression profile of a malignant rhabdoid tumor of the kidney. Cancer Genet Cytogenet. 2005;163(2):130–7.
Lee RS, et al. A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. J Clin Invest. 2012;122(8):2983–8.
Gadd S, et al. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest. 2010;90(5):724–38.
Perlman EJ. Pediatric renal cell carcinoma. Surg Pathol Clin. 2010;3(3):641–51.
Sausville JE, et al. Pediatric renal cell carcinoma. J Pediatr Urol. 2009;5(4):308–14.
Soller MJ, et al. Cytogenetic findings in pediatric renal cell carcinoma. Cancer Genet Cytogenet. 2007;173(1):75–80.
Spreafico F, et al. Renal cell carcinoma in children and adolescents. Expert Rev Anticancer Ther. 2010;10(12):1967–78.
Indolfi P, et al. Local lymph node involvement in pediatric renal cell carcinoma: a report from the Italian TREP project. Pediatr Blood Cancer. 2008;51(4):475–8.
Selle B, et al. Population-based study of renal cell carcinoma in children in Germany, 1980–2005: more frequently localized tumors and underlying disorders compared with adult counterparts. Cancer. 2006;107(12):2906–14.
Argani P, et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. Am J Pathol. 2001;159(1):179–92.
Argani P, Ladanyi M. Translocation carcinomas of the kidney. Clin Lab Med. 2005;25(2):363–78.
Argani P, et al. A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene. 2003;22(34):5374–8.
Schafernak KT, et al. Pediatric renal cell carcinoma as second malignancy: reports of two cases and a review of the literature. Can J Urol. 2007;14(6):3739–44.
Joshi DD, Banerjee T. Vascular endothelial growth factor (VEGF) receptor antibody bevacizumab (avastin) induces regression of renal cell carcinoma in an adolescent resulting in residual tumorectomy. Pediatr Blood Cancer. 2008;50(4):903–4.
Malouf GG, et al. Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network. Ann Oncol. 2010;21(9):1834–8.
Pwint TP, et al. An adult Xp11.2 translocation renal carcinoma showing response to treatment with sunitinib. Urol Oncol. 2011;29(6):821–4.
Schultz TD, et al. Papillary renal cell carcinoma: report of a rare entity in childhood with review of the clinical management. J Pediatr Surg. 2011;46(6):e31–4.
Antonelli A, et al. Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma. Cancer Genet Cytogenet. 2010;199(2):128–33.
Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537–44.
Downey RT, et al. CT and MRI appearances and radiologic staging of pediatric renal cell carcinoma. Pediatr Radiol. 2012;42(4):410–7. quiz 513–4.
Khanna G, et al. Cell carcinoma in children and adolescents: a summary of imaging findings from the Children’s Oncology Group. Pediatr Radiol. 2014;44(Suppl):S136.
Coogan CL, et al. Renal medullary carcinoma in patients with sickle cell trait. Urology. 1998;51(6):1049–50.
Gangireddy V, et al. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy. Clin Genitourin Cancer. 2012;10(2):134–9.
Swartz MA, et al. Renal medullary carcinoma: clinical, pathologic, immunohistochemical, and genetic analysis with pathogenetic implications. Urology. 2002;60(6):1083–9.
Baig MA, et al. Renal medullary carcinoma. J Natl Med Assoc. 2006;98(7):1171–4.
Hakimi AA, et al. Renal medullary carcinoma: the Bronx experience. Urology. 2007;70(5):878–82.
Walsh AM, et al. Response to radiation in renal medullary carcinoma. Rare Tumors. 2011;3(3):e32.
Assad L, et al. Cytologic features of renal medullary carcinoma. Cancer. 2005;105(1):28–34.
Avery RA, et al. Renal medullary carcinoma: clinical and therapeutic aspects of a newly described tumor. Cancer. 1996;78(1):128–32.
Khan A, et al. Renal medullary carcinoma: sonographic, computed tomography, magnetic resonance and angiographic findings. Eur J Radiol. 2000;35(1):1–7.
Davidson AJ, et al. Renal medullary carcinoma associated with sickle cell trait: radiologic findings. Radiology. 1995;195(1):83–5.
Medeiros LJ, et al. Oncocytoid renal cell carcinoma after neuroblastoma: a report of four cases of a distinct clinicopathologic entity. Am J Surg Pathol. 1999;23(7):772–80.
Lack EE, Cassady JR, Sallan SE. Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J Urol. 1985;133(5):822–8.
Dhall D, et al. Pediatric renal cell carcinoma with oncocytoid features occurring in a child after chemotherapy for cardiac leiomyosarcoma. Urology. 2007;70(1):178e13–5.
Katzman PJ, Schwartz JI. Chromophobe renal cell carcinoma in a child: case report and review of the literature. Pediatr Dev Pathol. 2007;10(2):125–8.
Vera-Badillo FE, Conde E, Duran I. Chromophobe renal cell carcinoma: a review of an uncommon entity. Int J Urol. 2012;19(10):894–900.
Amin MB, et al. Chromophobe renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 145 cases. Am J Surg Pathol. 2008;32(12):1822–34.
Przybycin CG, et al. Chromophobe renal cell carcinoma: a clinicopathologic study of 203 tumors in 200 patients with primary resection at a single institution. Am J Surg Pathol. 2011;35(7):962–70.
Volpe A, et al. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series. BJU Int. 2012;110(1):76–83.
Bartholow T, Parwani A. Renal primitive neuroectodermal tumors. Arch Pathol Lab Med. 2012;136(6):686–90.
Chu WC, et al. Primitive neuroectodermal tumour (PNET) of the kidney: a rare renal tumour in adolescents with seemingly characteristic radiological features. Pediatr Radiol. 2008;38(10):1089–94.
Ellinger J, et al. Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies. Urology. 2006;68(2):257–62.
Gonlusen G, et al. Primitive neuroectodermal tumor of the kidney: a rare entity. Int Urol Nephrol. 2001;33(3):449–51.
Jimenez RE, et al. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002;26(3):320–7.
Parham DM, et al. Primary malignant neuroepithelial tumors of the kidney: a clinicopathologic analysis of 146 adult and pediatric cases from the National Wilms’ Tumor Study Group Pathology Center. Am J Surg Pathol. 2001;25(2):133–46.
de Alava E, Gerald WL. Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 2000;18(1):204–13.
Kim MS, et al. Radiologic findings of peripheral primitive neuroectodermal tumor arising in the retroperitoneum. AJR Am J Roentgenol. 2006;186(4):1125–32.
Raney B, et al. Primary renal sarcomas in the Intergroup Rhabdomyosarcoma Study Group (IRSG) experience, 1972–2005: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2008;51(3):339–43.
Putnam AR, Wallentine JC. Diagnostic pathology. Pediatric neoplasms. 1st ed. Salt Lake City, UT: Amirsys; 2012.
Iacovelli R, et al. Clinical and pathological features of primary renal synovial sarcoma: analysis of 64 cases from 11 years of medical literature. BJU Int. 2012;110(10):1449–54.
Scarpato KR, et al. Primary renal synovial sarcoma in a 13-year-old boy. J Pediatr Surg. 2011;46(9):1849–51.
Divetia M, et al. Synovial sarcoma of the kidney. Ann Diagn Pathol. 2008;12(5):333–9.
Argani P, et al. Primary renal synovial sarcoma: molecular and morphologic delineation of an entity previously included among embryonal sarcomas of the kidney. Am J Surg Pathol. 2000;24(8):1087–96.
Fisher C. Diagnostic pathology. Soft tissue tumors. Salt Lake City, UT: Amirsys; 2011.
Perlmutter AE, et al. Primary synovial sarcoma of the kidney. Int J Urol. 2005;12(8):760–2.
Zakhary MM, et al. Magnetic resonance imaging features of renal synovial sarcoma: a case report. Cancer Imaging. 2008;8:45–7.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Shehata, B.M., Naguib, M.M., Lin, J., Khanna, G. (2015). Malignant Renal Tumors. In: Parham, D., Khoury, J., McCarville, M. (eds) Pediatric Malignancies: Pathology and Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1729-7_10
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1729-7_10
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1728-0
Online ISBN: 978-1-4939-1729-7
eBook Packages: MedicineMedicine (R0)